OMEGA THERAPEUTICS INC (OMGA) Stock Analyst Earnings Estimates
NASDAQ:OMGA - Nasdaq - US68217N1054 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.07M | 3.094M 49.47% | 8.706M 181.38% | 4.394M -49.53% | 6.747M 53.55% | 34.053M 404.71% | 259.91M 663.25% | 527.63M 103.00% | 885.1M 67.75% | 27.617M -96.88% | 16.001M -42.06% | ||
| EBITDA YoY % growth | -64.79M -135.60% | -101.21M -56.21% | -98.693M 2.49% | -61.49M 37.70% | -60.792M 1.13% | -87.822M -44.46% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -66.18M -130.99% | -102.77M -55.29% | -100.261M 2.44% | -66.505M 33.67% | -45.513M 31.56% | -26.244M 42.34% | -66.52M -153.47% | 113.08M 269.99% | 300.14M 165.42% | 554.15M 84.63% | 9.402M -98.30% | -2.675M -128.46% | |
| Operating Margin | N/A | -4,964.73% | -3,240.50% | -763.89% | -1,035.81% | -388.97% | -195.34% | 43.51% | 56.88% | 62.61% | 34.04% | -16.72% | |
| EPS YoY % growth | N/A | -2.14 18.13% | -1.81 15.42% | -1.19 34.35% | -0.80 32.62% | -0.45 43.95% | -0.77 -70.45% | 1.60 309.33% | 3.88 142.04% | 6.10 57.37% | 0.97 -84.11% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 43.49% | -0.18 50.42% | -0.20 33.70% | -0.20 32.00% | -0.22 -7.32% |
| Revenue Q2Q % growth | 1.456M 47.22% | 1.099M -53.43% | 1.099M -48.50% | 1.099M -57.92% | 1.099M -24.52% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.984M 42.10% | -10.093M 50.65% | -11.035M 33.44% | -11.719M 28.63% | -12.666M -5.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.30 25.00% | -0.28 | -0.02 | -6.31% |
| Q2 2024 Q2Q % growth | -0.30 44.44% | -0.37 | 0.07 | 19.51% |
| Q1 2024 Q2Q % growth | -0.36 28.00% | -0.34 | -0.02 | -5.88% |
| Q4 2023 Q2Q % growth | -0.37 42.19% | -0.46 | 0.09 | 19.12% |
| Q3 2023 Q2Q % growth | -0.40 25.93% | -0.54 | 0.14 | 25.81% |
| Q2 2023 Q2Q % growth | -0.54 | -0.52 | -0.02 | -4.39% |
| Q1 2023 Q2Q % growth | -0.50 -19.05% | -0.61 | 0.11 | 17.83% |
| Q4 2022 Q2Q % growth | -0.64 -45.45% | -0.64 | 0.00 | 0.40% |
| Q3 2022 Q2Q % growth | -0.54 5.26% | -0.63 | 0.09 | 14.06% |
| Q2 2022 Q2Q % growth | -0.54 83.93% | -0.53 | -0.01 | -2.30% |
| Q1 2022 Q2Q % growth | -0.42 | -0.58 | 0.16 | 27.44% |
| Q4 2021 Q2Q % growth | -0.44 | -0.54 | 0.10 | 18.61% |
| Q3 2021 Q2Q % growth | -0.57 | -0.49 | -0.08 | -16.42% |
| Q2 2021 Q2Q % growth | -3.36 | -1.23 | -2.13 | -172.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.612M 214.32% | 1.265M | 1.347M | 106.48% |
| Q2 2024 Q2Q % growth | 2.134M 181.16% | 967.98K | 1.166M | 120.46% |
| Q1 2024 Q2Q % growth | 2.36M 357.36% | 1.663M | 697K | 41.91% |
| Q4 2023 Q2Q % growth | 989K 33.65% | 581.4K | 407.6K | 70.11% |
| Q3 2023 Q2Q % growth | 831K 38.50% | 459K | 372K | 81.05% |
| Q2 2023 Q2Q % growth | 759K 58.13% | 459K | 300K | 65.36% |
| Q1 2023 Q2Q % growth | 516K 91.11% | 263.497K | 252.503K | 95.83% |
| Q4 2022 Q2Q % growth | 740K | 262.65K | 477.35K | 181.74% |
| Q3 2022 Q2Q % growth | 600K | 103.224K | 496.776K | 481.26% |
| Q2 2022 Q2Q % growth | 480K | 52.53K | 427.47K | 813.76% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 15.75% | 25.18% | 1.83% | -4.95% |
| Revenue | -4.71% | 101.52% | 0% | 23.82% |